Stilbene's Contribution in Hemorrhagic Stroke
二苯乙烯在出血性中风中的作用
基本信息
- 批准号:8059681
- 负责人:
- 金额:$ 21.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-01 至 2013-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAffectAnti-Inflammatory AgentsAnti-inflammatoryAntioxidantsAttentionAttenuatedAutologousBilirubinBiliverdineBloodBrainBrain EdemaBrain InjuriesBrain hemorrhageBrain regionC57BL/6 MouseCarbon MonoxideCellsCerebral hemisphere hemorrhageChronicCleaved cellConsumptionCorpus striatum structureCytoprotectionDataDoseElementsEnzymesEpidemiologic StudiesFerritinFinancial SupportFree RadicalsGeneral PopulationGenerationsGenetic TranscriptionGoalsGrapesHealth BenefitHealth PersonnelHeartHemeHemorrhageHippocampus (Brain)InjuryIronIschemic StrokeKnock-outKnockout MiceLaboratory miceMediatingMethodsModelingMusNerve DegenerationNeuraxisNeurologicNeuronsOralOral AdministrationOutcomeOxidation-ReductionOxidative StressOxygenasesPathologicPathway interactionsPlayPositioning AttributePredispositionPreventive MedicinePropertyProsencephalonProteinsReactive Oxygen SpeciesRecyclingRegulationResistanceResveratrolRiskRoleSafetySeedsSeveritiesSkinStilbenesStrokeSuperoxide DismutaseTechniquesTestingTimeToxic effectTraditional MedicineTranscriptional RegulationVascular DiseasesVasodilator AgentsWorkbrain cellcatalasecell growth regulationcollagenasegene inductionheme oxygenase-1inhibitor/antagonistinterestmature animalmouse modelnervous system disorderneurobehavioralneuron lossneuroprotectionpostnatalpre-clinicalpreconditioningpreventpromoterprophylacticpublic health relevancepuprecombinasered wineresearch studyresponsetert-Butylhydroperoxidetooltrans-resveratrol
项目摘要
DESCRIPTION (provided by applicant): The stilbene compound resveratrol is naturally present in grape skin and seeds and is found in particularly high concentrations in red wine. Epidemiological studies have shown that those who consume red wine have a reduced risk of vascular diseases, a phenomenon known as the French Paradox. Here, we document that pretreatment with resveratrol decreases ischemic stroke damage. Neuronal cell death in neurodegenerative conditions has been postulated to be mediated by free radical damage. Promising candidates to limit free radical-mediated damage are the endogenous antioxidant enzymes present in the central nervous system, such as catalase, superoxide dismutases, and heme oxygenases. Transcription of these cytoprotective proteins is under control of Nrf2, which plays a central role in the regulation of the cellular redox status. For example, we and other showed that heme oxygenase enzyme, which cleaves the prooxidant heme to form biliverdin/bilirubin (antioxidants), is protective. One goal would be to induce it, and of the compounds we tested, as shown in the preliminary data, resveratrol was a most potent inducer. Our preliminary data indicate that pretreatment of neurons with resveratrol was sufficient to provide neuroprotection, suggesting that cotreatment during oxidative stress is not necessary. The results so far imply that specific induction of genes under the control of Nrf2 could be a mechanism by which resveratrol exerts its neuroprotective actions in stroke. We will extend our ongoing inquiry into the beneficial effects of oral pretreatment with resveratrol against hemorrhagic stroke and determine whether it can reduce the severity of outcomes in mice subjected to the collagenase and autologous blood models of intracerebral hemorrhage (ICH). We will investigate the effect of acute and chronic daily oral administration of resveratrol on brain injury volume, brain edema, and neurobehavioral outcome deficits at different time points following hemorrhage and test whether these beneficial effects are attenuated in Nrf2 knockout mice. To further determine if resveratrol of protective in neurons and address possible cellular mechanisms of action, primary postnatal cultured neurons derived from Nrf2 knockout pups and matched controls will be pretreated with resveratrol and then tested for susceptibility to tert- butylhydroperoxide-induced free radical toxicity and heme, which is also a pro-oxidant. Notably, under pathologic conditions such as in ICH, heme reaches high toxic levels; it cannot be recycled and has to be degraded. Nrf2 can then induce various antioxidant enzymes. These results will indicate whether preconditioning of primary neurons is sufficient to afford neuroprotection and whether the effect is modulated by Nrf2. Understanding the efficacy and limitations/safety of natural compounds such as resveratrol in ischemic and hemorrhagic stroke may help the general public and healthcare providers to make informed decisions on whether resveratrol and similar bioactive extracts are efficacious as adjunct treatments for such devastating neurological diseases. It will also allow us to address possible mechanisms by which the oral consumption of the stilbene resveratrol could be neuroprotective and have the putative ability to provide the brain with cellular endogenous resistance to debilitating neurodegenerative conditions.
PUBLIC HEALTH RELEVANCE: For decades, the stilbene resveratrol and red wine have been suggested as preventive medicine to strengthen the heart and the brain, but the underlying cellular mechanisms are still unclear. Our preliminary results prompted us to focus our attention on resveratrol and test the hypothesis that the pathway leading to the regulation of the transcriptional factor Nrf2 could participate in resveratrol's neuroprotective function. Using preclinical laboratory mouse models, we will determine whether prophylactic consumption of resveratrol can prevent neurological decline and brain damage following hemorrhagic stroke, thus providing new pathways by which resveratrol could provide resistance to acute neurological disorders.
描述(由申请人提供):Stilbene化合物白藜芦醇自然存在于葡萄皮和种子中,并且在红酒中特别浓缩。流行病学研究表明,食用红酒的人患血管疾病的风险降低,这是一种称为法国悖论的现象。在这里,我们记录了白藜芦醇预处理会减少缺血性中风损伤。假定神经退行性疾病中的神经元细胞死亡是由自由基损伤介导的。有希望限制自由基介导的损害的有前途的候选者是中枢神经系统中存在的内源性抗氧化剂酶,例如过氧化氢酶,超氧化物歧化酶和血红素氧酶。这些细胞保护蛋白的转录受NRF2的控制,该蛋白在调节细胞氧化还原状态中起着核心作用。例如,我们和其他表明血红素氧酶酶(裂解)促氧化剂血红素形成双脂蛋白/胆红素(抗氧化剂)具有保护性。一个目标是诱导它,在我们测试的化合物中,如初步数据所示,白藜芦醇是最有效的诱导剂。我们的初步数据表明,用白藜芦醇对神经元进行预处理足以提供神经保护作用,这表明无需在氧化应激过程中进行共同治疗。迄今为止的结果表明,在NRF2控制下基因的特定诱导可能是白藜芦醇在中风中施加神经保护作用的机制。 我们将持续询问对毒s中风的口服预处理的有益作用,并确定它是否可以减少经受胶原酶和自体血液模型的小鼠的结局严重程度(ICH)。我们将研究白藜芦醇的急性和慢性每日口服给药对出血后不同时间点的脑损伤体积,脑水肿和神经行为结果缺陷的影响,并测试在NRF2敲除小鼠中这些有益效应是否会减弱。为了进一步确定神经元中保护性的白藜芦醇是否解决了可能的细胞作用机制,从NRF2敲除幼崽和匹配的对照组中得出的主要产后培养神经元将用白藜芦醇预处理,然后测试,以易于易于诱发的自由氧化氢诱导的自由氧诱导的自由氧诱导的自由基诱导的自由基毒性。值得注意的是,在ICH等病理状况下,血红素达到高毒性水平。它不能回收,必须降级。然后,NRF2可以诱导各种抗氧化剂酶。这些结果将表明原发性神经元的预处理是否足以负担神经保护作用,以及该效果是否由NRF2调节。 了解自然化合物(例如白藜芦醇)在缺血性和出血性中风等天然化合物的效果和局限性/安全性可能有助于公共和医疗保健提供者就白藜芦醇和类似的生物活性提取物做出明智的决定,是否有效地是对这种破坏性神经疾病的辅助治疗方法。它还将使我们能够解决可能具有神经保护性的细曲替氏菌的口服消耗的可能机制,并具有为大脑提供细胞内源性抗性神经退行性疾病的推定能力。
公共卫生相关性:数十年来,Stilbene白藜芦醇和红酒被认为是预防医学来增强心脏和大脑的预防医学,但是基本的细胞机制尚不清楚。我们的初步结果促使我们将注意力集中在白藜芦醇上,并检验了导致转录因子NRF2调节的途径可以参与白藜芦醇的神经保护功能。使用临床前实验室小鼠模型,我们将确定白藜芦醇的预防性消耗是否可以防止出血性中风后神经系统下降和脑损伤,从而提供新的途径,而白藜芦醇可以通过这些途径可以提供对急性神经系统疾病的抗性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sylvain DORE其他文献
Sylvain DORE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sylvain DORE', 18)}}的其他基金
Testing brain penetrant iron chelators and investigating putative clearance pathway in ICH
测试脑渗透铁螯合剂并研究 ICH 中假定的清除途径
- 批准号:
10201369 - 财政年份:2020
- 资助金额:
$ 21.76万 - 项目类别:
Potential stroke therapeutic efficacy of FumET-CORM through the Nrf2 pathway
FumET-CORM 通过 Nrf2 通路的潜在中风治疗功效
- 批准号:
9751526 - 财政年份:2019
- 资助金额:
$ 21.76万 - 项目类别:
Regulation and Implication of Hemoglobin Clearance in Subarachnoid Hemorrhagic Patients
蛛网膜下腔出血患者血红蛋白清除率的调节及意义
- 批准号:
9332485 - 财政年份:2016
- 资助金额:
$ 21.76万 - 项目类别:
Regulation and Implication of Hemoglobin Clearance in Subarachnoid Hemorrhagic Patients
蛛网膜下腔出血患者血红蛋白清除率的调节及意义
- 批准号:
9182501 - 财政年份:2016
- 资助金额:
$ 21.76万 - 项目类别:
Better Understanding of the Neuroprotective Mechanisms of Korean Ginseng in Strok
更好地了解高丽参对中风的神经保护机制
- 批准号:
9128625 - 财政年份:2012
- 资助金额:
$ 21.76万 - 项目类别:
Better Understanding of the Neuroprotective Mechanisms of Korean Ginseng in Strok
更好地了解高丽参对中风的神经保护机制
- 批准号:
8708765 - 财政年份:2012
- 资助金额:
$ 21.76万 - 项目类别:
Better Understanding of the Neuroprotective Mechanisms of Korean Ginseng in Strok
更好地了解高丽参对中风的神经保护机制
- 批准号:
8369356 - 财政年份:2012
- 资助金额:
$ 21.76万 - 项目类别:
Better Understanding of the Neuroprotective Mechanisms of Korean Ginseng in Strok
更好地了解高丽参对中风的神经保护机制
- 批准号:
8543642 - 财政年份:2012
- 资助金额:
$ 21.76万 - 项目类别:
Effect of Flavanol-Rich Cocoa Extract in Acute Neurodegenerative Conditions
富含黄烷醇的可可提取物对急性神经退行性疾病的作用
- 批准号:
8117138 - 财政年份:2010
- 资助金额:
$ 21.76万 - 项目类别:
Effect of Flavanol-Rich Cocoa Extract in Acute Neurodegenerative Conditions
富含黄烷醇的可可提取物对急性神经退行性疾病的作用
- 批准号:
7989678 - 财政年份:2010
- 资助金额:
$ 21.76万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 21.76万 - 项目类别:
Leveraging COVID-19 to modernize depression care for VA primary care populations
利用 COVID-19 实现 VA 初级保健人群的抑郁症护理现代化
- 批准号:
10636681 - 财政年份:2023
- 资助金额:
$ 21.76万 - 项目类别:
Establishment of a Bat Resource for Infectious Disease Research
建立用于传染病研究的蝙蝠资源
- 批准号:
10495114 - 财政年份:2023
- 资助金额:
$ 21.76万 - 项目类别:
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
- 批准号:
10456380 - 财政年份:2023
- 资助金额:
$ 21.76万 - 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 21.76万 - 项目类别: